Education

Invited Speakers

Seminars / Courses

Molecular Medicine for biologists for students of the University of Hohenheim

PhD Curriculum for PhD students at the IKP and the University of Tuebingen

Invited Speakers

2018
24.01.2018	Albert Bräuning, PhD German Federal Institute for Risk Assessment (BfR)	Food Safety at the German Federal Institute for Risk Assessment (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
05.12.2018	Klaus Mörike, MD University Hospital Tübingen	Clinical Studies – Design and Realization (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)

2017
24.05.2017	Joerg Albert, MD Robert-Bosch-Hospital	Physiology and pathophysiology of the digestive system (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
31.05.2017	Christian Schäfer, MD Robert-Bosch-Hospital	Physiology and pathophysiology of the liver (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
31.05.2017	Jun J. Yang, Ph.D. St. Jude Children's Research Hospital	Pharmacogenomics of Thiopurines and Precision Medicine: From Genomics to Clinical Actions
14.06.2017	Godehard Friedel, MD Robert-Bosch-Hospital - Schillerhoehe	Physiology and pathophysiology of the lungs (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
21.06.2017	Andreas Hartkopf, MD University Hospital Tuebingen	Physiology and pathophysiology of the breast (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”) (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
28.06.2017	Kilian Rapp, MD Robert-Bosch-Hospital	Physiological Specialties in Elderly Patients (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
05.07.2017	Peter Ong, MD Robert-Bosch-Hospital	Physiology and pathophysiology of the cardiovascular System (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
13.07.2017	Robert Feil, PhD University of Tuebingen	Seeing is believing: Combining biochemistry and mouse genetics to visualize physiology, pathophysiology and pharmacology
12.07.2017	Martin Kimmel, MD Robert-Bosch-Hospital	Physiology and pathophysiology of the kidneys (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
19.07.2017	Andreas Nüssler, MD University of Tuebingen	Cell culture approaches towards 3D micro-organ Engineering (Part of the PhD Curriculum with focus on ”Physiology and Pathophysiology of Organ Systems”)
18.09.2017	Sven Glaesker, MD University Hospital Brussels	Molecular and morphological pathogenesis in von Hippel-Lindau (VHL) disease
08.11.2017	Klaus Moerike, MD University Hospital Tuebingen	Arzneimitteltherapie kardialer Arrhythmien (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
15.11.2017	Robert Lukowski, PhD University Hospital Tuebingen	The NO-cGMP system: Implications for disease biology and therapy
22.11.2017	Reinhold Kerb, MD CRS Clinical Research GmbH	Drug Therapy of Diabetes, Obesity, Metabolic Syndrome (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
29.11.2017	Peter Muenzel University of Tuebingen	Gifte und Vergiftungen (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)
08.12.2017	Carsten Gruellich, MD NCT -National Center for Tumor Diseases Heidelberg Medical Oncology	Molekulare Heterogenität und therapiegetriebene Evolution des Nierenzellkarzinoms
11.12.2017	Markus Morkel, MD Charité - University Hospital Berlin	Organoids as a tool to assess oncogene characteristics and cancer signaling networks
13.12.2017	Robert Juette, PhD Institute of the History of Medicine, Robert Bosch Stiftung	Der Placebo Effekt: Past and Present (Part of the PhD Curriculum with focus on ”Selected Topics in Pharmacology and Toxicology”)

2016
04.05.2016	Walter Aulitzky, MD Robert-Bosch-Hospital	Introduction – Basic and Clinical Aspects (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
22.06.2016	Michael Schwarz, MD University Hospital Tuebingen	Mechanisms of Tumor Promotion (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
23.06.2016	Elfriede Nößner, PhD Helmholtz- Center Munich	“Enriched-in-renal-carcinoma dendritic cells” (ercDCs) are unique macrophages with a gene signature indicative of immune escape
29.06.2016	German Ott, MD Robert-Bosch-Hospital	Tumor Pathology – Where Morphology Meets Molecular Genetics (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
29.06.2016	Joachim Orth, PhD University of Freiburg	Regulation of bone cell differentiations by G protein deamidating toxins
13.07.2016	Michael Dengler, PhD The Walter & Eliza Hall Institute of Medical Research, Victoria, Australia	Control of apoptosis by the Bcl-2 family: Molecular mechanisms and therapeutic potential (Part of the PhD Curriculum with focus on ”Oncology, basic and clinical aspects”)
29.07.2016	Hannelore Daniel, PhD Technical University Munich (TUM)	We are all individuals – I am not
03.08.2016	Daniela Stöhr, PhD University of Stuttgart	Downregulation of TRAIL receptor expression in multicellular tumor spheroids: a reason for TRAIL resistance?
26.10.2016	Christina Justenhoven, PhD Bioscientia – Insititute of Medical Diagnostics, Ingelheim	Analysis of DNA Variations (Part of the PhD Curriculum with focus on ”Molecular and cell-biology methodology and selected “soft-skills” topics”)
23.11.2016	Marius Ueffing, PhD Medical Proteome Center Tübingen	Proteomics – From basic approaches to clinical applications
20.12.2016	Barbara Seliger, PhD Martin Luther University, Halle	How tumor cells escape immune resistance
21.12.2016	H.P. Rodemann, PhD University Hospital Tübingen	Soft Dkills I: Good scientific practice (Part of the PhD Curriculum with focus on ”Molecular and cell-biology methodology and selected “soft-skills” topics”)

2015
03.02.2015	Edgar Serfling, PhD University of Wuerzburg	NFATc1 Controls the Fate of Lymphocytes by Controlling their Metabolic Capacity
04.02.2015	Peter Münzel, PhD University Hospital Tuebingen	Gifte und Vergiftungen
11.02.2015	Klaus Mörike, MD University Hospital Tuebingen	Drug Therapy in Special Populations: Pregnancy and Old Age
18.02.2015	Christian Harteneck, PhD University Hospital Tuebingen	Pharmacological Mudulation of Ion Channels
16.03.2015	Jörn Lausen, PhD Georg-Speyer-Haus, Frankfurt	Epigenetic mechanisms in hematopoiesis as molecular therapeutic targets
24.04.2015	Monica Campillos, PhD Helmholtz-Zentrum München	From pertubations of mammalian organisms to phenotypes
04.11.2015	Marieke Coenen, PhD and Maroeska te Loo, PhD Radboud University Medical Center, Nijmegen	Pharmacogenetics of inflammatory bowel disease and childhood cancer: from research to diagnostics
09.12.2015	Klaus Mörike, MD University Hospital Tübingen	Clinical Studies – Design and Realization

2014
22.01.2014	Thomas Wheeler-Schilling, PhD University Hospital Tübingen	What a scientist should know beyond science
28.01.2014	Steven de Jong, PhD Dept. of Medical Oncology, University Medical Center Groningen	Targeting novel pathways to overcome platinum-based resistance in testicular and ovarian cancer
20.02.2014	Dik van Gent, MD, PhD Erasmus Universiteit Rotterdam, Netherlands	Exploiting the DNA damage response for personalized tumor treatment
09.05.2014	Gerhard Treiber, MD Gastro Zentrum Hirslanden Klinik, Schänisweg, Aarau, Switzerland	Physiology and Pathophysiology of Oesophagus and Stomach
14.05.2014	Christian Schäfer, MD Gastroenterology, Robert-Bosch-Hospital, Stuttgart	Physiology and Pathophysiology of the liver
23.05.2014	Ali Yilmaz, MD Cardiology, University Hospital Münster	Physiology and Pathophysiology of the Cardiovascular System
11.06.2014	Godehard Friedel, MD Klinik Schillerhöhe	Physiology and Pathophysiology of the lungs
09.07.2014	Niko Braun, MD Robert-Bosch-Hospital, Stuttgart	Physiology and Pathophysiology of the kidneys
15.07.2014	Sara Y. Brucker, MD Medical Director, Dept. of Female Health, University Hospital Tuebingen	Physiology and Pathophysiology of the breast
27.10.2014	Margarida D. Amaral, PhD BioISI, Faculty of Sciences, University of Lisboa, Portugal	Cystic Fibrosis: Novel Personalized Therapies Targeting the Molecular Defect
29.10.2014	Klaus Mörike, MD Dept. of Clinical Pharmacology, University Hospital Tuebingen	Drug Treatment of Cardiac Arrhythmia
12.11.2014	Robert Jütte, Dr. phil. Institute of the History of Medicine, Stuttgart	The Placebo Effect: Past and Present
19.11.2014	Ulrich Lauer, MD Dept. Internal Medicine I, University Hospital Tuebingen	Virotherapie therapiefraktärer Tumorerkrankungen
21.11.2014	Björn Windshügel, PhD Fraunhofer Institut, Hamburg	Computational Approaches in Nuclear Receptor Research
26.11.2014	Walter Aulitzky, MD Dept. of Oncology, Robert-Bosch-Hospital	Anticancer Drugs - Mechanisms and Therapy
04.12.2014	Julia Schüler Oncotest GmbH, Freiburg	Oncology Platforms at Oncotest
10.12.2014	Reinhold Kerb, MD Medical Director, CRS Clinical Research GmbH, Lübeck	Drug Therapy of Diabetes, Obesity, Metabolic Syndrome

2013
07.01.2013	Dr. Matthias Haag Institute of Genetics, University of Cologne	Quantification of Mitochondrial Phospholipids by ESI-MS/MS
18.01.2013	Monilola Olayioye, PhD Institute of Cell Biology and Immunology, University of Stuttgart	ErbB receptors: Novel regulatory mechanisms and signaling crosstalk
23.01.2013	Stephan Urban, PhD Department of Molecular Virology, University Hospital Heidelberg	Entry and entry inhibition of Hepatitis B virus (HBV): The role of sodium taurocholate co-transporting polypeptide (NTCP/SLC10A) as a functional HBV receptor
18.02.2013	Friedrich Pürner, MD Women's penitentiary, Aichach	Medizin hinter Gittern - Alltag ärztlicher Arbeit im Knast
17.04.2013	Walter Aulitzky, MD Robert-Bosch-Hospital, Stuttgart	Introduction - Basic and Clinical Aspects in Oncology
24.04.2013	German Ott, MD Robert-Bosch-Hospital, Stuttgart	Tumor Pathology
15.05.2013	Christoph Ulmer, MD Robert-Bosch-Hospital, Stuttgart	Importance of visceral surgery in metastasis
29.05.2013	Birgit Spänkuch, MD University Hospital Tübingen	The role of Plk1 for the cell cycle in cancer and primary cells
19.06.2013	Michael Schwarz, MD University Hospital Tübingen	Mechanisms of tumor promotion
19.07.2013	Saskia de Wildt, MD, PhD Dept. of Surgery and Intensive Care, Erasmus MC Sophia Children's Hospital	Drug metabolism in children: the interplay of age, disease and genetics
24.10.2013	Nico Scheer / John Bial Taconic GmbH, Cologne and Yecuris Portland, USA	Genetically and liver humanized mouse models and advanced human hepatocytes for improved prediction of the ADMET characteristics of compounds in humans
06.11.2013	Christina Justenhoven, PhD Bioscientia, Institute of Medical Diagnostics, Ingelheim	Analysis of DNA variations
26.11.2013	Kerstin Junker, MD University Hospital Saarland	Molekulargenetische Charakterisierung des Nierenzellkarzinoms zur individuellen Prognosedifferenzierung und Therapiewahl

2012
11.01.2012	Prof. Klaus Mörike Clinical Pharmacology, University Hospital Tübingen	Drug Therapy in Special Populations: Advanced Age and Pregnancy
18.01.2012	Prof. Klaus Mörike Clinical Pharmacology, University Hospital Tübingen	Drug Therapy of Cardiac Arrhytmia
19.01.2012	Dario Cattaneo, PhD Unit of Clinical Pharmacology, "Luigi Sacco" University Hospital, Milan, Italy	Clinical Pharmacology of antiretroviral drugs
24.01.2012	Ludmilla Prokunina-Olsson, PhD Laboratory of Translational Genomics, National Cancer Institute, NIH, Bethedsda, USA	Genetics of cellular detoxification and its role in bladder cancer susceptibility - the mysterious case of the UGT1A locus
15.02.2012	Adriano Henney, PhD Program Director of the German Virtual Liver Network	Systems approaches to 21st Century Medicine
22.02.2012	Prof. Jörn Lötsch Hospital and Faculty of Medicine, Johann Wolfgang Goethe-University, Frankfurt / Main	Drug therapy against pain: pharmacokinetics, pharmacogenetics, and drug development
23.03.2012	Prof. Dr. Werner Mewes Helmholtz Zentrum München; Deutsches Forschungszentrum für Gesundheit und Umwelt	Systems Biology from Correlation to Causation for Personalized Medicine
23.04.2012	Prof. Dr. Marc Reymond Marienhospital Herne, Klinikum der Ruhr-Universität Bochum	Normotherme Intraperitoneale Aerosol Chemotherapie (NIPAC): ein neuer Ansatz in der Therapie der Peritonealkarzinose
03.05.2012	Prof. Dr. Swen Hülsmann Universitätsmedizin Göttingen	Neuron-Glia-Interaction: Are brainstem astrocytes different?
29.05.2012	Dr. Ute Albrecht Universitätsklinikum Düsseldorf	Crosstalk of mediators: Communication between macrophages and hepatocytes
05.06.2012	Prof. Dr. Andreas J. Fallgatter Ärztlicher Direktor der Klinik für Allgemeine Psychiatrie und Psychotherapie mit Poiklinik, Eberhard Karls Universität Tübingen	Brain functional endophenotypes in Attention Deficit- / Hyperactivity Disorder - a pathway to individualized psychiatry?
09.10.2012	Dr. Susann Irgang Max Planck Institut für Molekulare Pflanzenphysiologie, Golm	Metabolic regulation during the inhibition of the 'Target of rapamycin' Kinase in Chlamydomonas reinhadtii
29.10.2012	Dipl. Biochem. Stefanie Schmidt Max Planck Institut für Molekulare Pflanzenphysiologie, Golm	Reil mediated leaf development in the cold
29.11.2012	Prof. Dr. Guenter Schwarz Institute of Biochemistry, Department of Chemistry & Center for Molecular Medicine, University of Cologne	Biochemistry of Molybdenum: Pathways, Enzymes, and neurodegenerative Diseases
11.12.2012	Dr. Florian Schröder Max Planck Institut für Molekulare Pflanzenphysiologie, Golm	Brassinosteroid-dependet leaf growth

2011
19.01.2011	PD Dr. Peter Bauer Medical Genetics, University of Tuebingen	Next Generation-Sequencing for DNA and RNA.
09.02.2011	Prof. Dr. Peter Jansen Department of Hepatology, Academic Medical Center, Amsterdam, The Netherlands	Multidrug Resistance Transporters and miRNAs Expression in Hepatocellular Carcinoma.
06.04.2011	PD Dr. Susanne Ammon-Treiber Clinical Pharmacology, University Hospital Tübingen	The isolated perfused lung as a model in lung pharmacology.
29.06.2011	Dr. Niko Braun Robert-Bosch-Hospital, Stuttgart	Physiology and Pathophysiology of the kidney.
13.07.2011	Prof. Dr. Tanja Fehm University Women's Hospital, Tübingen	Physiology and Pathophysiology of the breast.
05.08.2011	Prof. Dr. Leszek Wojnowski University Hospital, Johanns Gutenberg-University Mainz	CYP3As and their regulators - lessons from the past.
22.09.2011	Dr. Nico Scheer Head of ADMET R&D, TaconicArtemis GmbH, Köln	Humanized mouse models for pharmacokinetic and safety profiling of compounds.
16.11.2011	Prof. Dr. Robert Jütte Director of the Insitute for the History of Medicine of the Robert Bosch Foundation, Stuttgart	The Placebo Effect: Past and Present
23.11.2011	Dr. Petra Knupfer Head of the office of the Ethics Committee at the State Medical Chamber of Baden-Wuerttemberg, Stuttgart	Composition and tasks of Research Ethics Committees (RECs).
28.11.2011	Prof. Luc Pellerin Directeur a.i., Department of Physiology, University of Lausanne, Switzerland	Nuroenergetics: regulations and roles of monocarboxylate transporters
05.12.2011	Dr. Peter Stopfer Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach	Pharmacokinetics in Drug Development
07.12.2011	Prof. Christian Harteneck Deputy Head of the Department of Pharmacology and Experimental Therapy (APET), University of Tuebingen	Pharmacological modulation of ion channels
14.12.2011	Dr. Sebastian Graf von Kielmansegg University of Mannheim, Department of German and Foreign Public Law, International Law and European Law	Legal Regulation of clinical Studies

2010
08.03.2010	Dr. Carina Hellberg Ludwig Institute for Cancer Research, Uppsala, Sweden	T-cell protein tyrosie phophatase regulates the M2 pyruvate kinase activity.
31.03.2010	Dr.-Ing. Jürgen Friedmann Vice-President Corporate Intellectual Property Patents Electronics, Robert Bosch GmbH	Von der Idee zum Patent
27.05.2010	Dr. Manfred Rauh University Hospital Erlangen	LC-MS/MS in der Steroidanalytik
25.10.2010	Prof. Dr. Dietrich Keppler German Cancer Research Center (DKFZ), Heidelberg	Uptake and Efflux Transporters of Human Hepatocytes.

2009
28.01.2009	Prof. Dr. med. Martin Wehling University Hospital Mannheim	Nutzenanalyse in Deutschland: Götterdämmerung oder weiter so?
29.01.2009	Univ.-Prof. Dr. med. Karsten Schrör University Hospital Düsseldorf	Pharmakokinetik und Antiplättchenwirkung von Thienopyridine
23.03.2009	Prof. Dr. med. Martina Muckenthaler University Hospital Heidelberg	Regulation of systemic iron homeostasis by miR122a
05.05.2009	Prof. Michael S. Phillips, Ph.D Université de Montréal	Development and optimization of a broad-based ADME genotyping system in clinical trials
12.05.2009	Dr. med. Lusine Danielyan University Hospital Tübingen	Intranasal delivery of cells to the brain
26.10.2009	Dr. med. Andreas Benesic Prof. Dr. Alexander L. Gerbes University Hospital Munich Großhadern	Metaheps - interessante Zellen aus peripheren Monozyten
29.10.2009	Dr. Jan Korbel European Molecular Biology Laboratory, Heidelberg	Global mapping of coy-number variants in humans - approaches and applications
10.12.2009	Dr. Carole Devaux, Ph.D. University of Luxembourg	Collaboration with Africa for HIV and AIDS: Challenges and Opportunities

2008
17.01.2008	Prof. Ramiro Jover University of Valencia, Spain	Regulation of human cytochrome P450 genes by liver-enriched transcription factors: Application to the development of metabolically competent hepatic cell models
20.02.2008	PD Dr. Lütjohann University of Bonn	Steroidal Marker of Cholesterol and Bile Acid Metabolism
05.03.2008	Prof. Dr. Alfons Meindl University Hospital 'rechts der Isar', Munich	Monogen, heterogen, polygen - Genetische Formen des familiären Mammakarzinoms
29.04.2008	Prof V. Craig Jordan Fox Chase Cancer Center, Philadelphia, USA	Development and Current Role of Tamoxifen and Raloxifen in the Treatment or Prevention of Breast Cancer and Osteoporosis
11.06.2008	Dr. Hajo Otten, Patent Lawyer Witte, Welle & Partner, Stuttgart	Patente und geistiges Eigentum in Medizin und Biotechnologie - eine Einführung
24.06.2008	Prof. Dr. Werner Lubitz Universitäy of Vienna, Austra	Bacterial Ghost Platform Technology
09.07.2008	Prof. Jens Schröder University of Schleswig-Holstein	Antimicrobial Peptides: Local Host Response Elements
17.07.2008	Dr. Rene Krieg Bruker Daltronik GmbH	MALDI Imaging, Molecular Histology and Class Imaging – Novel Techniques for Tissue Based Proteomics
18.07.2008	Prof. Paavo Honkakosi University of Kuopio, Finland	Unraveling the ligand specificity of nuclear receptor CAR
09.09.2008	Prof. Lutz Heide University of Tübingen	Genetic engineering of microorganisms for the generation of new antibiotics
15.09.2008	Dr. Jörg Lippert Bayer Technology Services GmbH	Mechanistische Modellierung und Ihre Anwendungen in der klinischen Pharmakologie
29.09.2008	Professor Amin Rostami-Hodjegan University of Sheffield, UK	Systems Pharmacology: Putting Things Together
10.10.2008	Prof. Jose Pedro Gil Karolinska Institute, Sweden	Artemisin derivative combination therapy – a malaria chemotherapy under global implementation
17.10.2008	Prof. Meinhard Kieser University Hospital Heidelberg	Fallzahlberechnung unter Unsicherheit - Welche Möglichkeiten bieten flexible Studiendesigns?